Search
Search Results
##search.searchResults.foundPlural##
-
EVALUATION OF USING EMPIRIC GLYCOPEPTIDES IN ACCORDANCE WITH THE IDSA GUIDELINE IN HEMATOLOGIC MALIGNANCY PATIENTS WITH FEBRILE NEUTROPENIA Empiric glycopeptide use in neutropenic fever
1617PDF: 1155HTML: 265 -
Acquired Hemophilia A successfully treated with rituximab
2197PDF: 1188HTML: 1518Figure 1: 218 -
TREATMENT OF ADVANCED SYSTEMIC MASTOCYTOSIS WITH MIDOSTAURIN: PRACTICAL GUIDANCE FOR OPTIMAL THERAPY AND MANAGEMENT Advanced systemic mastocytosis and midostaurin
1375PDF: 1098HTML: 434 -
HODGKIN LYMPHOMA IN OLDER PATIENTS: AN ORPHAN DISEASE?
3014PDF: 1413HTML: 3727Untitled: 221Untitled: 231Untitled: 204 -
MODULATING EFFECT OF THE ?158 G? (C?T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS
1643PDF: 936HTML: 1448Table: 217 -
PERIOPERATIVE MANAGEMENT OF SICKLE CELL DISEASE: A NARRATIVE REVIEW
10358PDF: 3338HTML: 1632 -
THE EVOLVING ROLE OF RADIOTHERAPY IN EARLY STAGE HODGKIN’S LYMPHOMA
2326PDF: 980HTML: 6860Figure 1: 201 -
INCIDENCE OF ACUTE MYELOID LEUKEMIA AFTER BREAST CANCER
3421PDF: 995HTML: 2993 -
REFRACTORY THROMBOCYTOPENIA AND NEUTROPENIA: A DIAGNOSTIC CHALLENGE
12962PDF: 1734HTML: 4352Cover letter: 226Figure 1: 235 -
ANTIFUNGAL PROPHYLAXIS IN IMMUNOCOMPROMISED PATIENTS
4422PDF: 1432HTML: 2192 -
THE ROLE OF THE CAROTID DOPPLER EXAMINATION IN THE EVALUATION OF ATHEROSCLEROTIC CHANGES IN BETA THALASSEMIA PATIENTS
2268PDF: 1027HTML: 3068Untitled: 245 -
TREATMENT OF ACUTE MYELOID LEUKEMIA WITH 20-30% BONE MARROW BLASTS
2991PDF: 1057HTML: 5644 -
Diagnosis of del(5q) MDS, 14 years after JAK-2 positive PV appearance: complete remission of both diseases with lenalidomide monotherapy
2930PDF: 800HTML: 1310Blood Count trend before and during lenalidomide treatment: 206Light micrograph of bone marrow biopsy of a patient with PV and 5q deletion: 214 -
OLDER ADULTS WITH PH NEGATIVE ACUTE LYMPHOBLASTIC LEUKEMIA: A MONOCENTRIC EXPERIENCE ON CONSECUTIVE PATIENTS AGED MORE THAN 55 YEARS Older Adults with Ph Negative Acute Lymphoblastic Leukemia
1439PDF: 619Suppl. Files: 377HTML: 175 -
EPIDEMIOLOGICAL OVERVIEW OF HODGKIN LYMPHOMA ACROSS THE MEDITERRANEAN BASIN
3757PDF: 1269HTML: 5093Incidence age-standardized rates for HL across the Mediterranean basin: 236 -
ATRA induced Reactive Hemophagocytosis: A Case Report
1291PDF: 632HTML: 2911ATRA induced Reactive Hemophagocytosis: A Case Report: 222 -
DIAGNOSIS AND SUBCLASSIFICATION OF ACUTE LYMPHOBLASTIC LEUKEMIA
9360PDF: 6217HTML: 88096Fig.1b: 224Fig.1c: 224Fig.2a: 207Fig.2b: 206Fig.4: 228Fig.2c: 208Fig.3: 212Tab.1: 266Tab.2: 246Tab.3: 227Tab.4: 256Fig1a: 222 -
OPTIMIZING TREATMENT, MINIMIZING RISK: THERAPEUTIC DRUG MONITORING IN HEMATOLOGICAL MALIGNANCIES
1667PDF: 1910Suppl. Files: 217HTML: 109 -
A MULTICENTER EXPERIENCE FROM LEBANON IN CHILDHOOD AND ADOLESCENT ACUTE MYELOID LEUKEMIA:HIGH RATE OF EARLY DEATH IN CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA.
3344PDF: 1162HTML: 7748cover letter paper final AML: 245 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
1232PDF: 868Html: 202 -
The diagnostic pitfalls of mucormycosis
1025PDF: 749HTML: 292 -
Guest Editor: G. Castaman GENE THERAPY FOR HEMOPHILIA: FACTS AND QUANDARIES IN THE 21ST CENTURY GENE THERAPY FOR HEMOPHILIA
2249PDF: 1991HTML: 526







